
Haitham Amer
Dr. Amer is currently working as a dean of Faculty of Veterinary Medicine, Egyptian Chinese University, Egypt. He is also a professor of Virology at Faculty of Veterinary Medicine, Cairo University (FVM-CU) and served as a former vice dean for graduate studies and scientific research, and chairman of the Virology department at FVM-CU. Dr. Amer received his PhD in virology from Cairo University in 2006. The main scope of his PhD was the use of baculovirus expression vector system (BEVS) for production of recombinant viral proteins and virus-like particles for use as possible candidates in vaccines and diagnostics. During his master and PhD, he shared in the establishment of BEVS and hybridoma technology for the first time in his university.
Dr. Amer also served as a postdoctoral fellow in the molecular immunology department, Robert Koch Institute, Germany, where he succeeded in the development of new system for accurate mRNA quantification of the Xcr-1 gene using Taqman real-time PCR. Dr. Amer has contributed to 17 research grants (3 as PI, and 4 as Co-PI) funded by foundations in Egypt, Germany, USA, and Saudi Arabia. He shared in conducting pilot studies in the fields of molecular virology, immunology and vaccinology that were reflected in the form of scientific publications (47), thesis (20), presentations in national and international conferences/seminars (30), GenBank submissions (297), and awards (12).
The current research projects of Dr. Amer are focusing on: 1) studying the genetic makeup of the prevalent Egyptian strains of animal and poultry viruses; 2) development of improved tools/kits for diagnosis of virus infections; 3) the use of modern biotechnology techniques for construction and evaluation of new vaccine candidates.
Dr. Amer is currently serving as a general secretary of the Egyptian Society of Virology (since 2022), and the editor-in-chief of International Journal of Veterinary Sciences and Medicine (Q1 Veterinary Sciences), and Veterinary Medical Journal Giza (Since 2022). He is a member of the Institutional Animal Care and Use Committee of Cairo University and the arbitrators for promotion of professors and associate professors (Pre-clinical Veterinary Sciences – Microbiology and Parasitology), Supreme Council of Universities. Dr. Amer also established a new bylaw for the postgraduate studies (Credit hour system) at Faculty of Veterinary Medicine, Cairo University.
Dr. Amer also served as a postdoctoral fellow in the molecular immunology department, Robert Koch Institute, Germany, where he succeeded in the development of new system for accurate mRNA quantification of the Xcr-1 gene using Taqman real-time PCR. Dr. Amer has contributed to 17 research grants (3 as PI, and 4 as Co-PI) funded by foundations in Egypt, Germany, USA, and Saudi Arabia. He shared in conducting pilot studies in the fields of molecular virology, immunology and vaccinology that were reflected in the form of scientific publications (47), thesis (20), presentations in national and international conferences/seminars (30), GenBank submissions (297), and awards (12).
The current research projects of Dr. Amer are focusing on: 1) studying the genetic makeup of the prevalent Egyptian strains of animal and poultry viruses; 2) development of improved tools/kits for diagnosis of virus infections; 3) the use of modern biotechnology techniques for construction and evaluation of new vaccine candidates.
Dr. Amer is currently serving as a general secretary of the Egyptian Society of Virology (since 2022), and the editor-in-chief of International Journal of Veterinary Sciences and Medicine (Q1 Veterinary Sciences), and Veterinary Medical Journal Giza (Since 2022). He is a member of the Institutional Animal Care and Use Committee of Cairo University and the arbitrators for promotion of professors and associate professors (Pre-clinical Veterinary Sciences – Microbiology and Parasitology), Supreme Council of Universities. Dr. Amer also established a new bylaw for the postgraduate studies (Credit hour system) at Faculty of Veterinary Medicine, Cairo University.
less
Uploads
Books by Haitham Amer
Papers by Haitham Amer
epithelial sloughing, syncytium formation, heterophilic exudation, and development of eosinophilic intranuclear inclusion bodies. Infectious laryngotracheitis virus (ILTV) antigen was detected in the tracheal epithelium, infiltrated inflammatory cells, and syncytial cells, using immunohistochemistry. PCR targeting a portion of the thymidine kinase gene was further utilized to confirm the presence of ILTV DNA. The complete coding sequences of three envelope glycoprotein genes, gG,
gD, and gJ, and a partial sequence of the infected cell polypeptide 4 (ICP4) gene from samples representing all of the farms and disease outbreaks were determined. Five prototype strains with unique sequences were chosen for detailed molecular characterization. Sequence comparisons and phylogenetic analysis of the partial ICP4 gene revealed that two strains were chicken embryo origin (CEO)-vaccine-like strains, and three were tissue culture origin (TCO)-vaccine-like strains. Analysis of the gJ gene sequence indicated that all of the strains were CEO vaccine-like strains. It was predicted that the latter three strains were recombinants of CEO- and TCO-vaccine-like strains. In conclusion, immunohistochemistry coupled with multigenomic PCR sequencing proved to be efficient for identification and typing of ILTV strains during disease outbreaks. Both CEO-vaccine-like and recombinant virus strains were circulating in Egypt during the 2018 and 2019 outbreaks.